STOCK TITAN

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Integer has made no recommendation on whether noteholders should exercise the conversion option.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Rhea-AI Summary

Integer Holdings (ITGR) opened a conversion window for its 2.125% Convertible Senior Notes due 2028, beginning October 1, 2026.

Holders may convert through the close of business on December 31, 2026. The conversion rate is 11.4681 shares per $1,000 principal amount, equivalent to approximately $87.20 per share. Settlement is in cash up to principal; Integer may settle any excess in cash, common shares or both.

The notes became convertible because the stock's last reported sale price exceeded 130% of the applicable conversion price on at least 20 trading days within the 30 consecutive trading days ending on the last trading day of the quarter ended September 30, 2026. Future conversion eligibility will follow the indenture's terms.

Loading...
Loading translation...

Positive

  • None.

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.Cash settlement up to principal is required for notes that holders elect to convert.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Common shares may settle amounts above principal, potentially diluting existing holders at Integer's election.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2026, and ending at the close of business on December 31, 2026. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company’s common stock or a combination thereof, at the Company’s election, in respect of the remainder, if any, of the Company’s conversion obligation in excess of the aggregate principal amount of the Notes being converted. Any determination regarding the convertibility of the Notes during future periods will be made in accordance with the terms of the Indenture governing the Notes.

The Notes became convertible because the last reported sale price of shares of the Company’s common stock, for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the calendar quarter ended September 30, 2026, was greater than 130% of the conversion price in effect on each applicable trading day.

The Notes are convertible at a conversion rate of 11.4681 shares of common stock per $1,000 principal amount of Notes, which is equivalent to a conversion price of approximately $87.20 per share of common stock.

The Company has issued a notice to holders with respect to the Conversion Option specifying the applicable terms, conditions and procedures. The notice is available through The Depository Trust Company or by requesting a copy from Wilmington Trust, National Association, which is serving as the conversion agent, at:

Wilmington Trust, National Association
1310 Silas Deane Highway
Wethersfield, CT 06109
Attn: Integer Holdings Corporation Notes Administrator

None of the Company, its Board of Directors or its employees has made or is making any representation or recommendation to any holder as to whether to exercise or refrain from exercising the Conversion Option.

This press release is not an offer to sell, nor a solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state or jurisdiction in which the offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Integer®

Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world, serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. The company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.

Investor Relations: 
Kristen Stewart 
kristen.stewart@integer.net 
551-337-3973 



FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When can holders convert Integer Holdings' 2.125% notes due 2028?

Holders may convert the notes from October 1, 2026, through the close of business on December 31, 2026. Conversion is optional for holders; eligibility in future periods will be determined under the indenture governing the notes.

What is the conversion rate for Integer Holdings' notes due 2028?

The conversion rate is 11.4681 common shares per $1,000 principal amount, equivalent to approximately $87.20 per share. Conversion is settled in cash up to principal, with any excess settled in cash, common shares or a combination at Integer's election.

How can Integer Holdings noteholders obtain the conversion instructions?

Holders can obtain the notice containing conversion terms, conditions and procedures through The Depository Trust Company or request a copy from Wilmington Trust, National Association, the conversion agent. Written requests may be directed to the Integer Holdings Corporation Notes Administrator, 1310 Silas Deane Highway, Wethersfield, CT 06109.

Keep reading